40.39
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Cogent Biosciences (NASDAQ:COGT) Reaches New 52-Week HighWhat's Next? - MarketBeat
Cogent Biosciences (COGT): Evaluating Valuation After Positive Phase 3 Cancer Trial Results and New Drug Plans - Yahoo Finance
Top Biotech Stocks To ConsiderNovember 20th - MarketBeat
Biotech Star Cogent Rides High On Breakthrough Trial Hopes - Finimize
Will Cogent Biosciences' (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Finviz
Will Cogent Biosciences’ (COGT) Breakthrough Therapy Transform GIST Treatment? Analysts Think So - Insider Monkey
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cogent Biosciences (NASDAQ:COGT) Sets New 12-Month HighStill a Buy? - MarketBeat
Technical Reactions to COGT Trends in Macro Strategies - news.stocktradersdaily.com
Mintz Advises on Cogent Biosciences Inc.’s Concurrent Public Offerings of $345 Million of Common Stock and $230 Million in Aggregate Principal Amount of 1.625% Convertible Senior Notes Due 2031 - Mintz
Cogent Biosciences stock hits 52-week high at 36.31 USD By Investing.com - Investing.com Canada
COGT Stock Skyrockets 120% in a Month: Here's What You Need to Know - Yahoo Finance
Cogent Biosciences stock hits 52-week high at 36.31 USD - Investing.com India
What earnings revisions data tells us about Cogent Biosciences Inc.Earnings Beat & Reliable Trade Execution Plans - newser.com
Cogent Biosciences : COGT Jefferies London 2025 - MarketScreener
Comparing Cogent Biosciences Inc. in custom built stock radarsJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Cogent Biosciences (COGT) Price Target Increased by 93.94% to 43.52 - MSN
Cogent Biosciences Completes $230M Convertible Notes Offering - TipRanks
[8-K] Cogent Biosciences, Inc. Reports Material Event | COGT SEC FilingForm 8-K - Stock Titan
Cogent Biosciences, Inc. Bonds — Corporate Bond Rates - TradingView
Will Cogent Biosciences Inc. stock maintain dividend yield2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Profund Advisors LLC Has $145,000 Stock Holdings in Cogent Biosciences, Inc. $COGT - MarketBeat
COGT6232219 Bond Analysis — Key Metrics - TradingView
COGT6232219 Bond Price and Chart — FINRA:COGT6232219 - TradingView
Cogent Biosciences: Soaring On Blowout GIST DataI Expect More Upside (NASDAQ:COGT) - Seeking Alpha
427,342 Shares in Cogent Biosciences, Inc. $COGT Purchased by Candriam S.C.A. - MarketBeat
FY2025 Earnings Estimate for COGT Issued By HC Wainwright - MarketBeat
10 Market Movers That Made Millionaires in a Week - Insider Monkey
Can Cogent Biosciences Inc. stock rebound after recent weaknessWeekly Profit Report & Expert Approved Trade Ideas - newser.com
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress - Finviz
Can Cogent Biosciences Inc. stock weather global recessionWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Is Cogent Biosciences Inc. stock a buy before product launchesJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Fox Run Management L.L.C. Trims Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat
How Cogent Biosciences Inc. stock benefits from tech adoptionTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
COGT6232219 Bond Coupon Analysis — Rate & Payments - TradingView
Is Cogent Biosciences Inc a good long term investmentMarket Correction Analysis & Free Dashboard to Track Market Momentum - earlytimes.in
COGENT BIOSCIENCES Earnings Preview: Recent $COGT Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Cogent Biosciences (NASDAQ:COGT) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - The Manila Times
HC Wainwright & Co. Maintains Cogent Biosciences (COGT) Buy Recommendation - Nasdaq
Top Biotech Stocks To Follow TodayNovember 12th - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):